glp-1 levels in type 2 diabetes GLP-1-based therapies for diabetes: from single, dual and triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome Type 2 diabetes risk alleles

Phase 2 studies showed patients losing up to 15% of their body weight after eight months

About author: Bella Lindemann, FDN-P Bella Lindemann is the founder and lead practitioner at The Functional Gut Health Clinic

In the ongoing study of healthy aging, scientists continue to explore novel compounds that may influence metabolism, cellular function, and age-related changes

In skincare, they are studied for their ability to

This has been suggested to underpin the effects seen after RYGB surgery on glycemia and appetite, although the reduction in fecal SCFAs as observed postoperatively in many studies [2,3,4,5] seems to contradict such a mode of action

Mass Spectrometry (MS) Mass spectrometry provides a high level of precision and sensitivity when analyzing glutathione